Abstract
Chronic oral anticoagulation (OAC) treatment is mandatory in patients with mechanical heart valves, the majority of the patients with atrial fibrillation (AF), patients with deep venous thrombosis, pulmonary embolism and left ventricular thrombi. Patients on OAC, who are referred for percutaneous coronary intervention/stenting (PCI), account for about 5% of the whole population undergoing PCI [1]. Conversely, approximately 70–80% of AF patients have indications for continuous OAC, and coronary artery disease (CAD) is present in more than 20% of AF population [2,3].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have